Chemical modification of iGb3 increases IFN-γ production by hepatic NKT cells

International Immunopharmacology

Volumn 8, Issue 5, 2008, Pages 645-653

  Shang, Pingping ^a   Zhang, Cai ^a,b   Xia, Chengfeng ^c   Chen, Wenlan ^c   Han, Qiuju ^b   Wang, Peng George ^b,c   Zhang, Jian ^b   Tian, Zhigang ^b  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Chemically modification; Glycolipid; IFN ; IL 4; Natural killer T cells

Indexed keywords

4 HO ISOGLOBOTRIHEXOSYLCERAMIDE; 4''' DH ISOGLOBOTRIHEXOSYLCERAMIDE; CD1D ANTIGEN; CERAMIDE DERIVATIVE; GAMMA INTERFERON; GLYCOLIPID; HYDROXYL GROUP; INTERLEUKIN 4; ISOGLOBOTRIHEXOSYLCERAMIDE; PHYTOSPHINGOSINE; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL POLARITY; CELL POPULATION; CHEMICAL MODIFICATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG ACTIVITY; DRUG STRUCTURE; FLOW CYTOMETRY; IN VIVO STUDY; LIVER; LIVER CELL; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL LINE; CYTOKINES; FLOW CYTOMETRY; GLOBOSIDES; INTERFERON TYPE II; KILLER CELLS, NATURAL; LIVER; MALE; MICE; MICE, INBRED C57BL; STRUCTURE-ACTIVITY RELATIONSHIP; TRIHEXOSYLCERAMIDES;

EID: 41149122994     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.01.003     Document Type: Article

References (33)

1. Nishimura T., Kitamura H., Iwakabe K., Yahata T., Ohta A., Sato M., et al. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int Immunol 12 (2000) 987-994
2. Gadola S.D., Koch M., Marles-Wright J., Lissin N.M., Shepherd D., Matulis G., et al. Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors. J Exp Med 203 (2006) 699-710
3. Brigl M., van den Elzen P., Chen X., Meyers J.H., Wu D., Wong C.H., et al. Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors. J Immunol 176 (2006) 3625-3634
4. Prigozy T.I., Naidenko O., Qasba P., Elewaut D., Brossay L., Khurana A., et al. Glycolipid antigen processing for presentation by CD1d molecules. Science 291 (2001) 664-667
5. Wu D., Zajonc D.M., Fujio M., Sullivan B.A., Kinjo Y., Kronenberg M., et al. Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d. Proc Natl Acad Sci U S A 103 (2006) 3972-3977
6. Chang Y.J., Huang J.R., Tsai Y.C., Hung J.T., Wu D., Fujio M., et al. Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids. Proc Natl Acad Sci U S A 104 (2007) 10299-10304
7. Smyth M.J., Crowe N.Y., Pellicci D.G., Kyparissoudis K., Kelly J.M., Takeda K., et al. Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. Blood 99 (2002) 1259-1266
8. Maeda M., Yanagawa Y., Iwabuchi K., Minami K., Nakamaru Y., Takagi D., et al. IL-21 enhances dendritic cell ability to induce interferon-gamma production by natural killer T cells. Immunobiology 212 (2007) 537-547
9. Leite-De-Moraes M.C., Hameg A., Pacilio M., Koezuka Y., Taniguchi M., Van Kaer L., et al. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. J Immunol 166 (2001) 945-951
10. Ko S.Y., Ko H.J., Chang W.S., Park S.H., Kweon M.N., and Kang C.Y. alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor. J Immunol 175 (2005) 3309-3317
11. Smyth M.J., Wallace M.E., Nutt S.L., Yagita H., Godfrey D.I., and Hayakawa Y. Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer. J Exp Med 201 (2005) 1973-1985
12. Singh A.K., Wilson M.T., Hong S., Olivares-Villagómez D., Du C., Stanic A.K., et al. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med 194 (2001) 1801-1811
13. Nakagawa R., Nagafune I., Tazunoki Y., Ehara H., Tomura H., Iijima R., et al. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice. J Immunol 166 (2001) 6578-6584
14. Dong Z., Wei H., Sun R., and Tian Z. The roles of innate immune cells in liver injury and regeneration. Cell Mol Immunol 4 (2007) 241-252
15. Tupin E., Nicoletti A., Elhage R., Rudling M., Ljunggren H.G., Hansson G.K., et al. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J Exp Med 199 (2004) 417-422
16. Ito K., Karasawa M., Kawano T., Akasaka T., Koseki H., Akutsu Y., et al. Involvement of decidual Valpha14 NKT cells in abortion. Proc Natl Acad Sci U S A 97 (2000) 740-744
17. Zhou D., Mattner J., Cantu III C., Schrantz N., Yin N., Gao Y., et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306 (2004) 1786-1789
18. Zhou D. The immunological function of iGb3. Curr Protein Pept Sci 7 (2006) 325-333
19. Xia C., Yao Q., Schuemann J., Rossy E., Chen W., Zhu L., et al. Synthesis and biological evaluation of α-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3). Bioorg Med Chem Lett 16 (2006) 2195-2199
20. Xia C., Schümann J., Emmanuel R., Zhang Y., Chen W., Zhang W., et al. Modification of the ceramide moiety of isoglobotrihexosylceramide on its agonist activity in stimulation of invariant natural killer T cells. J Med Chem 50 (2007) 3489-3496
21. Chen W., Xia C., Wang J., Thapa P., Li Y., Nadas J., et al. Synthesis and structure-activity relationship study of isoglobotrihexosylceramide (iGb3) analogs. J Org Chem 72 (2007) 9914-9923
22. Zhang J., Dong Z., Zhou R., Luo D., Wei H., and Tian Z. Isolation of lymphocytes and their innate immune characterizations from liver, intestine, lung and uterus. Cell Mol Immunol 2 (2005) 271-280
23. Crowe N.Y., Uldrich A.P., Kyparissoudis K., Hammond K.J., Hayakawa Y., Sidobre S., et al. Glycolipid antigen drives rapid expansion and sustained cytokine production by NKT cells. J Immunol 171 (2003) 4020-4027
24. Leite-de-Moraes M.C., Herbelin A., Gouarin C., Koezuka Y., Schneider E., and Dy M. Fas/Fas ligand interactions promote activation-induced cell death of NKT lymphocytes. J Immunol 165 (2000) 4367-4371
25. Parekh V.V., Singh A.K., Wilson M.T., Olivares-Villagómez D., Bezbradica J.S., Inazawa H., et al. Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids. J Immunol 173 (2004) 3693-3706
26. Godfrey D.I., McConville M.J., and Pellicci D.G. Chewing the fat on natural killer T cell development. J Exp Med 203 (2006) 2229-2232
27. Godfrey D.I., and Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 114 (2004) 1379-1388
28. Sidobre S., Hammond K.J., Bénazet-Sidobre L., Maltsev S.D., Richardson S.K., Ndonye R.M., et al. The T cell antigen receptor expressed by Valpha14i NKT cells has a unique mode of glycosphingolipid antigen recognition. Proc Natl Acad Sci U S A 101 (2004) 12254-12259
29. Oki S., Chiba A., Yamamura T., and Miyake S. The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J Clin Invest 113 (2004) 1631-1640
30. Fujii S., Shimizu K., Hemmi H., Fukui M., Bonito A.J., Chen G., et al. Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice. Proc Natl Acad Sci U S A 103 (2006) 11252-11257
31. Sullivan B.A., and Kronenberg M. Activation or anergy: NKT cells are stunned by α-galactosylceramide. J Clin Invest 115 (2005) 2328-2329
32. Parekh V.V., Wilson M.T., Olivares-Villagómez D., Singh A.K., Wu L., Wang C., et al. Glycolipid antigen induces long-term natural killer T cell anergy in mice. J Clin Invest 115 (2005) 2572-2583
33. Chang Y.J., Huang J.R., Tsai Y.C., Hung J.T., Wu D., Fujio M., et al. Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids. Proc Natl Acad Sci U S A 104 (2007) 10299-10304